USD 16.41
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2024 | 1217.33 Billion JPY | 6.38% |
2023 | 1144.27 Billion JPY | 11.53% |
2022 | 1025.94 Billion JPY | 8.03% |
2021 | 949.65 Billion JPY | 9.37% |
2020 | 868.28 Billion JPY | 11.44% |
2019 | 779.14 Billion JPY | 12.06% |
2018 | 695.26 Billion JPY | 11.57% |
2017 | 623.16 Billion JPY | 17.93% |
2016 | 528.4 Billion JPY | 38.88% |
2015 | 380.46 Billion JPY | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 FY | 1217.33 Billion JPY | 6.38% |
2024 Q1 | 298.26 Billion JPY | -0.01% |
2024 Q4 | 306.87 Billion JPY | 2.48% |
2024 Q3 | 299.44 Billion JPY | -4.25% |
2024 Q2 | 312.75 Billion JPY | 4.86% |
2023 Q2 | 295.03 Billion JPY | 10.2% |
2023 Q1 | 267.71 Billion JPY | -0.68% |
2023 FY | 1144.27 Billion JPY | 11.53% |
2023 Q4 | 298.29 Billion JPY | 5.32% |
2023 Q3 | 283.23 Billion JPY | -4.0% |
2022 Q2 | 259.43 Billion JPY | 4.25% |
2022 Q1 | 248.86 Billion JPY | 4.02% |
2022 FY | 1025.94 Billion JPY | 8.03% |
2022 Q4 | 269.54 Billion JPY | 8.64% |
2022 Q3 | 248.1 Billion JPY | -4.37% |
2021 Q1 | 232.5 Billion JPY | 2.42% |
2021 Q2 | 244.15 Billion JPY | 5.01% |
2021 Q4 | 239.24 Billion JPY | 2.35% |
2021 FY | 949.65 Billion JPY | 9.37% |
2021 Q3 | 233.75 Billion JPY | -4.26% |
2020 FY | 868.28 Billion JPY | 11.44% |
2020 Q2 | 217.01 Billion JPY | 3.12% |
2020 Q4 | 226.99 Billion JPY | 6.16% |
2020 Q1 | 210.44 Billion JPY | 5.15% |
2020 Q3 | 213.82 Billion JPY | -1.47% |
2019 Q4 | 200.12 Billion JPY | 4.43% |
2019 FY | 779.14 Billion JPY | 12.06% |
2019 Q3 | 191.63 Billion JPY | -2.9% |
2019 Q2 | 197.36 Billion JPY | 3.87% |
2019 Q1 | 190.01 Billion JPY | 5.23% |
2018 Q2 | 173.65 Billion JPY | 3.98% |
2018 FY | 695.26 Billion JPY | 11.57% |
2018 Q4 | 180.57 Billion JPY | 3.76% |
2018 Q1 | 167 Billion JPY | 5.03% |
2018 Q3 | 174.03 Billion JPY | 0.22% |
2017 Q2 | 157.36 Billion JPY | 2.43% |
2017 FY | 623.16 Billion JPY | 17.93% |
2017 Q4 | 159 Billion JPY | 3.82% |
2017 Q3 | 153.15 Billion JPY | -2.67% |
2017 Q1 | 153.63 Billion JPY | 1.45% |
2016 Q1 | 112.33 Billion JPY | 0.0% |
2016 FY | 528.4 Billion JPY | 38.88% |
2016 Q4 | 151.43 Billion JPY | 3.73% |
2016 Q3 | 145.98 Billion JPY | 23.03% |
2016 Q2 | 118.65 Billion JPY | 5.62% |
2015 FY | 380.46 Billion JPY | 0.0% |
2015 Q2 | 95.98 Billion JPY | 3.79% |
2015 Q3 | 93.84 Billion JPY | -2.23% |
2015 Q1 | 92.48 Billion JPY | 5.95% |
2014 Q4 | 87.29 Billion JPY | 2.65% |
2014 Q3 | 85.03 Billion JPY | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Alternative Energy Partners, Inc. | - USD | -Infinity% |
Allstar Health Brands, Inc. | - USD | -Infinity% |
Beijing Tong Ren Tang Chinese Medicine Company Limited | 195.23 Million USD | -623413.141% |
Café Serendipity Holdings, Inc. | 44.55 Thousand USD | -2732216261.8% |
Decision Diagnostics Corp. | - USD | -Infinity% |
Health Advance Inc. | - USD | -Infinity% |
HealthWarehouse.com, Inc. | 20.28 Million USD | -6001570.534% |
LIGAND PHARMACEUTICAL INC | 131.31 Million USD | -926944.336% |
MedGen, Inc. | 1.05 USD | -115937047618947.619% |
Omni Health, Inc. | 4.69 Million USD | -25926700.719% |
Oxford Investments Holdings Inc. | 61.16 Thousand USD | -1990189054.283% |
Pineapple, Inc. | 381.89 Thousand USD | -318766822.412% |
ScripsAmerica, Inc. | 30.85 Million USD | -3945298.062% |